▶ 調査レポート

腎臓がんの世界市場(~2026年)

• 英文タイトル:Global Kidney Cancer Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。腎臓がんの世界市場(~2026年) / Global Kidney Cancer Market Size, Status and Forecast 2020-2026 / MRC2-11QY12460資料のイメージです。• レポートコード:MRC2-11QY12460
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は腎臓がんのグローバル市場について調査・分析したレポートです。種類別(腎細胞癌(RCC)、移行上皮癌(TCC))市場規模、用途別(手術、免疫療法、化学療法、放射線療法)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別腎臓がんの競争状況、市場シェア
・世界の腎臓がん市場:種類別市場規模 2015年-2020年(腎細胞癌(RCC)、移行上皮癌(TCC))
・世界の腎臓がん市場:種類別市場規模予測 2021年-2026年(腎細胞癌(RCC)、移行上皮癌(TCC))
・世界の腎臓がん市場:用途別市場規模 2015年-2020年(手術、免疫療法、化学療法、放射線療法)
・世界の腎臓がん市場:用途別市場規模予測 2021年-2026年(手術、免疫療法、化学療法、放射線療法)
・北米の腎臓がん市場分析:米国、カナダ
・ヨーロッパの腎臓がん市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの腎臓がん市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の腎臓がん市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの腎臓がん市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Merck、Novartis、AstraZeneca、Bristol-Myers Squibb、Pfizer、Roche、Amgen、Argos Therapeutics、Aveo Pharmaceuticals、Bayer、Exelixis、Incyte、Allergan
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Kidney cancer is a type of cancer that starts in the cells in the kidney.
The growth of the market is attributed to increasing incidence of kidney cancers and increasing ill lifestyle changes which gets worsen with addiction of tobacco and alcohol. Furthermore, overexposure to radiation during treatment testicular cancer, growing awareness program, and increasing mortality due to kidney cancer are boosting the kidney cancer market.

Market Analysis and Insights: Global Kidney Cancer Market
The global Kidney Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Kidney Cancer Scope and Market Size
Kidney Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Kidney Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Merck
Novartis
AstraZeneca
Bristol-Myers Squibb
Pfizer
Roche
Amgen
Argos Therapeutics
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Allergan

Market segment by Type, the product can be split into
Renal Cell Carcinoma (RCC)
Transitional Cell Carcinoma (TCC)
Market segment by Application, split into
Surgery
Immunotherapy
Chemotherapy
Radiation Therapy

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Kidney Cancer Revenue
1.4 Market by Type
1.4.1 Global Kidney Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Renal Cell Carcinoma (RCC)
1.4.3 Transitional Cell Carcinoma (TCC)
1.5 Market by Application
1.5.1 Global Kidney Cancer Market Share by Application: 2020 VS 2026
1.5.2 Surgery
1.5.3 Immunotherapy
1.5.4 Chemotherapy
1.5.5 Radiation Therapy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Kidney Cancer Market Perspective (2015-2026)
2.2 Global Kidney Cancer Growth Trends by Regions
2.2.1 Kidney Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Kidney Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Kidney Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Kidney Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Kidney Cancer Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Kidney Cancer Players by Market Size
3.1.1 Global Top Kidney Cancer Players by Revenue (2015-2020)
3.1.2 Global Kidney Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Kidney Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Kidney Cancer Market Concentration Ratio
3.2.1 Global Kidney Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Kidney Cancer Revenue in 2019
3.3 Kidney Cancer Key Players Head office and Area Served
3.4 Key Players Kidney Cancer Product Solution and Service
3.5 Date of Enter into Kidney Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Kidney Cancer Historic Market Size by Type (2015-2020)
4.2 Global Kidney Cancer Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Kidney Cancer Market Size by Application (2015-2020)
5.2 Global Kidney Cancer Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Kidney Cancer Market Size (2015-2020)
6.2 Kidney Cancer Key Players in North America (2019-2020)
6.3 North America Kidney Cancer Market Size by Type (2015-2020)
6.4 North America Kidney Cancer Market Size by Application (2015-2020)

7 Europe
7.1 Europe Kidney Cancer Market Size (2015-2020)
7.2 Kidney Cancer Key Players in Europe (2019-2020)
7.3 Europe Kidney Cancer Market Size by Type (2015-2020)
7.4 Europe Kidney Cancer Market Size by Application (2015-2020)

8 China
8.1 China Kidney Cancer Market Size (2015-2020)
8.2 Kidney Cancer Key Players in China (2019-2020)
8.3 China Kidney Cancer Market Size by Type (2015-2020)
8.4 China Kidney Cancer Market Size by Application (2015-2020)

9 Japan
9.1 Japan Kidney Cancer Market Size (2015-2020)
9.2 Kidney Cancer Key Players in Japan (2019-2020)
9.3 Japan Kidney Cancer Market Size by Type (2015-2020)
9.4 Japan Kidney Cancer Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Kidney Cancer Market Size (2015-2020)
10.2 Kidney Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Kidney Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Kidney Cancer Market Size by Application (2015-2020)

11 India
11.1 India Kidney Cancer Market Size (2015-2020)
11.2 Kidney Cancer Key Players in India (2019-2020)
11.3 India Kidney Cancer Market Size by Type (2015-2020)
11.4 India Kidney Cancer Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Kidney Cancer Market Size (2015-2020)
12.2 Kidney Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Kidney Cancer Market Size by Type (2015-2020)
12.4 Central & South America Kidney Cancer Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Kidney Cancer Introduction
13.1.4 Merck Revenue in Kidney Cancer Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Kidney Cancer Introduction
13.2.4 Novartis Revenue in Kidney Cancer Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview
13.3.3 AstraZeneca Kidney Cancer Introduction
13.3.4 AstraZeneca Revenue in Kidney Cancer Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Details
13.4.2 Bristol-Myers Squibb Business Overview
13.4.3 Bristol-Myers Squibb Kidney Cancer Introduction
13.4.4 Bristol-Myers Squibb Revenue in Kidney Cancer Business (2015-2020)
13.4.5 Bristol-Myers Squibb Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Kidney Cancer Introduction
13.5.4 Pfizer Revenue in Kidney Cancer Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview
13.6.3 Roche Kidney Cancer Introduction
13.6.4 Roche Revenue in Kidney Cancer Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Amgen
13.7.1 Amgen Company Details
13.7.2 Amgen Business Overview
13.7.3 Amgen Kidney Cancer Introduction
13.7.4 Amgen Revenue in Kidney Cancer Business (2015-2020)
13.7.5 Amgen Recent Development
13.8 Argos Therapeutics
13.8.1 Argos Therapeutics Company Details
13.8.2 Argos Therapeutics Business Overview
13.8.3 Argos Therapeutics Kidney Cancer Introduction
13.8.4 Argos Therapeutics Revenue in Kidney Cancer Business (2015-2020)
13.8.5 Argos Therapeutics Recent Development
13.9 Aveo Pharmaceuticals
13.9.1 Aveo Pharmaceuticals Company Details
13.9.2 Aveo Pharmaceuticals Business Overview
13.9.3 Aveo Pharmaceuticals Kidney Cancer Introduction
13.9.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2015-2020)
13.9.5 Aveo Pharmaceuticals Recent Development
13.10 Bayer
13.10.1 Bayer Company Details
13.10.2 Bayer Business Overview
13.10.3 Bayer Kidney Cancer Introduction
13.10.4 Bayer Revenue in Kidney Cancer Business (2015-2020)
13.10.5 Bayer Recent Development
13.11 Exelixis
10.11.1 Exelixis Company Details
10.11.2 Exelixis Business Overview
10.11.3 Exelixis Kidney Cancer Introduction
10.11.4 Exelixis Revenue in Kidney Cancer Business (2015-2020)
10.11.5 Exelixis Recent Development
13.12 Incyte
10.12.1 Incyte Company Details
10.12.2 Incyte Business Overview
10.12.3 Incyte Kidney Cancer Introduction
10.12.4 Incyte Revenue in Kidney Cancer Business (2015-2020)
10.12.5 Incyte Recent Development
13.13 Allergan
10.13.1 Allergan Company Details
10.13.2 Allergan Business Overview
10.13.3 Allergan Kidney Cancer Introduction
10.13.4 Allergan Revenue in Kidney Cancer Business (2015-2020)
10.13.5 Allergan Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Kidney Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Kidney Cancer Revenue
Table 3. Ranking of Global Top Kidney Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Kidney Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Renal Cell Carcinoma (RCC)
Table 6. Key Players of Transitional Cell Carcinoma (TCC)
Table 7. Global Kidney Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Kidney Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Kidney Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Kidney Cancer Market Share by Regions (2015-2020)
Table 11. Global Kidney Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Kidney Cancer Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Kidney Cancer Market Growth Strategy
Table 17. Main Points Interviewed from Key Kidney Cancer Players
Table 18. Global Kidney Cancer Revenue by Players (2015-2020) (Million US$)
Table 19. Global Kidney Cancer Market Share by Players (2015-2020)
Table 20. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer as of 2019)
Table 21. Global Kidney Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Kidney Cancer Product Solution and Service
Table 24. Date of Enter into Kidney Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Kidney Cancer Market Size by Type (2015-2020) (Million US$)
Table 27. Global Kidney Cancer Market Size Share by Type (2015-2020)
Table 28. Global Kidney Cancer Revenue Market Share by Type (2021-2026)
Table 29. Global Kidney Cancer Market Size Share by Application (2015-2020)
Table 30. Global Kidney Cancer Market Size by Application (2015-2020) (Million US$)
Table 31. Global Kidney Cancer Market Size Share by Application (2021-2026)
Table 32. North America Key Players Kidney Cancer Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Kidney Cancer Market Share (2019-2020)
Table 34. North America Kidney Cancer Market Size by Type (2015-2020) (Million US$)
Table 35. North America Kidney Cancer Market Share by Type (2015-2020)
Table 36. North America Kidney Cancer Market Size by Application (2015-2020) (Million US$)
Table 37. North America Kidney Cancer Market Share by Application (2015-2020)
Table 38. Europe Key Players Kidney Cancer Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Kidney Cancer Market Share (2019-2020)
Table 40. Europe Kidney Cancer Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Kidney Cancer Market Share by Type (2015-2020)
Table 42. Europe Kidney Cancer Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Kidney Cancer Market Share by Application (2015-2020)
Table 44. China Key Players Kidney Cancer Revenue (2019-2020) (Million US$)
Table 45. China Key Players Kidney Cancer Market Share (2019-2020)
Table 46. China Kidney Cancer Market Size by Type (2015-2020) (Million US$)
Table 47. China Kidney Cancer Market Share by Type (2015-2020)
Table 48. China Kidney Cancer Market Size by Application (2015-2020) (Million US$)
Table 49. China Kidney Cancer Market Share by Application (2015-2020)
Table 50. Japan Key Players Kidney Cancer Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Kidney Cancer Market Share (2019-2020)
Table 52. Japan Kidney Cancer Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Kidney Cancer Market Share by Type (2015-2020)
Table 54. Japan Kidney Cancer Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Kidney Cancer Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Kidney Cancer Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Kidney Cancer Market Share (2019-2020)
Table 58. Southeast Asia Kidney Cancer Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Kidney Cancer Market Share by Type (2015-2020)
Table 60. Southeast Asia Kidney Cancer Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Kidney Cancer Market Share by Application (2015-2020)
Table 62. India Key Players Kidney Cancer Revenue (2019-2020) (Million US$)
Table 63. India Key Players Kidney Cancer Market Share (2019-2020)
Table 64. India Kidney Cancer Market Size by Type (2015-2020) (Million US$)
Table 65. India Kidney Cancer Market Share by Type (2015-2020)
Table 66. India Kidney Cancer Market Size by Application (2015-2020) (Million US$)
Table 67. India Kidney Cancer Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Kidney Cancer Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Kidney Cancer Market Share (2019-2020)
Table 70. Central & South America Kidney Cancer Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Kidney Cancer Market Share by Type (2015-2020)
Table 72. Central & South America Kidney Cancer Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Kidney Cancer Market Share by Application (2015-2020)
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Product
Table 77. Merck Revenue in Kidney Cancer Business (2015-2020) (Million US$)
Table 78. Merck Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Product
Table 82. Novartis Revenue in Kidney Cancer Business (2015-2020) (Million US$)
Table 83. Novartis Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Product
Table 87. AstraZeneca Revenue in Kidney Cancer Business (2015-2020) (Million US$)
Table 88. AstraZeneca Recent Development
Table 89. Bristol-Myers Squibb Company Details
Table 90. Bristol-Myers Squibb Business Overview
Table 91. Bristol-Myers Squibb Product
Table 92. Bristol-Myers Squibb Revenue in Kidney Cancer Business (2015-2020) (Million US$)
Table 93. Bristol-Myers Squibb Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Product
Table 97. Pfizer Revenue in Kidney Cancer Business (2015-2020) (Million US$)
Table 98. Pfizer Recent Development
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche Product
Table 102. Roche Revenue in Kidney Cancer Business (2015-2020) (Million US$)
Table 103. Roche Recent Development
Table 104. Amgen Company Details
Table 105. Amgen Business Overview
Table 106. Amgen Product
Table 107. Amgen Revenue in Kidney Cancer Business (2015-2020) (Million US$)
Table 108. Amgen Recent Development
Table 109. Argos Therapeutics Business Overview
Table 110. Argos Therapeutics Product
Table 111. Argos Therapeutics Company Details
Table 112. Argos Therapeutics Revenue in Kidney Cancer Business (2015-2020) (Million US$)
Table 113. Argos Therapeutics Recent Development
Table 114. Aveo Pharmaceuticals Company Details
Table 115. Aveo Pharmaceuticals Business Overview
Table 116. Aveo Pharmaceuticals Product
Table 117. Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2015-2020) (Million US$)
Table 118. Aveo Pharmaceuticals Recent Development
Table 119. Bayer Company Details
Table 120. Bayer Business Overview
Table 121. Bayer Product
Table 122. Bayer Revenue in Kidney Cancer Business (2015-2020) (Million US$)
Table 123. Bayer Recent Development
Table 124. Exelixis Company Details
Table 125. Exelixis Business Overview
Table 126. Exelixis Product
Table 127. Exelixis Revenue in Kidney Cancer Business (2015-2020) (Million US$)
Table 128. Exelixis Recent Development
Table 129. Incyte Company Details
Table 130. Incyte Business Overview
Table 131. Incyte Product
Table 132. Incyte Revenue in Kidney Cancer Business (2015-2020) (Million US$)
Table 133. Incyte Recent Development
Table 134. Allergan Company Details
Table 135. Allergan Business Overview
Table 136. Allergan Product
Table 137. Allergan Revenue in Kidney Cancer Business (2015-2020) (Million US$)
Table 138. Allergan Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kidney Cancer Market Share by Type: 2020 VS 2026
Figure 2. Renal Cell Carcinoma (RCC) Features
Figure 3. Transitional Cell Carcinoma (TCC) Features
Figure 4. Global Kidney Cancer Market Share by Application: 2020 VS 2026
Figure 5. Surgery Case Studies
Figure 6. Immunotherapy Case Studies
Figure 7. Chemotherapy Case Studies
Figure 8. Radiation Therapy Case Studies
Figure 9. Kidney Cancer Report Years Considered
Figure 10. Global Kidney Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Kidney Cancer Market Share by Regions: 2020 VS 2026
Figure 12. Global Kidney Cancer Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Kidney Cancer Market Share by Players in 2019
Figure 15. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Kidney Cancer Revenue in 2019
Figure 17. North America Kidney Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Kidney Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Kidney Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Kidney Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Kidney Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Kidney Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Kidney Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed